InFo Hämatologie + Onkologie最新文献

筛选
英文 中文
Bessere Behandlungsmöglichkeit nach Osimertinib-Versagen 奥希替尼失败后的更好治疗方案
InFo Hämatologie + Onkologie Pub Date : 2024-05-01 DOI: 10.1007/s15004-024-0575-4
Daniel Hamberger
{"title":"Bessere Behandlungsmöglichkeit nach Osimertinib-Versagen","authors":"Daniel Hamberger","doi":"10.1007/s15004-024-0575-4","DOIUrl":"https://doi.org/10.1007/s15004-024-0575-4","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"2005 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141027283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
KI in der Medizin: Begrifflichkeiten, Chancen und Risiken 医疗领域的人工智能:术语、机遇和风险
InFo Hämatologie + Onkologie Pub Date : 2024-05-01 DOI: 10.1007/s15004-024-0567-4
Corinne Widmer
{"title":"KI in der Medizin: Begrifflichkeiten, Chancen und Risiken","authors":"Corinne Widmer","doi":"10.1007/s15004-024-0567-4","DOIUrl":"https://doi.org/10.1007/s15004-024-0567-4","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"54 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141033856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PD-1-Hemmer bei NSCLC neoadjuvant zugelassen PD-1 抑制剂获批用于 NSCLC 的新辅助治疗
InFo Hämatologie + Onkologie Pub Date : 2024-05-01 DOI: 10.1007/s15004-024-0587-0
Redaktion Facharztmagazine
{"title":"PD-1-Hemmer bei NSCLC neoadjuvant zugelassen","authors":"Redaktion Facharztmagazine","doi":"10.1007/s15004-024-0587-0","DOIUrl":"https://doi.org/10.1007/s15004-024-0587-0","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"12 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141054019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kurative Operation reicht oft nicht 治愈性手术往往不够
InFo Hämatologie + Onkologie Pub Date : 2024-05-01 DOI: 10.1007/s15004-024-0589-y
F. Klein
{"title":"Kurative Operation reicht oft nicht","authors":"F. Klein","doi":"10.1007/s15004-024-0589-y","DOIUrl":"https://doi.org/10.1007/s15004-024-0589-y","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"55 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141042553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beschleunigte Zulassungen von Onkologika: Geht es zu schnell? 肿瘤药物的加速审批:是否太快了?
InFo Hämatologie + Onkologie Pub Date : 2024-05-01 DOI: 10.1007/s15004-024-0568-3
M. Borchers
{"title":"Beschleunigte Zulassungen von Onkologika: Geht es zu schnell?","authors":"M. Borchers","doi":"10.1007/s15004-024-0568-3","DOIUrl":"https://doi.org/10.1007/s15004-024-0568-3","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"39 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141033766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Die Zukunft der Melanomtherapie 黑色素瘤治疗的未来
InFo Hämatologie + Onkologie Pub Date : 2024-05-01 DOI: 10.1007/s15004-024-0600-7
Martha-Luise Storre
{"title":"Die Zukunft der Melanomtherapie","authors":"Martha-Luise Storre","doi":"10.1007/s15004-024-0600-7","DOIUrl":"https://doi.org/10.1007/s15004-024-0600-7","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"9 9","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141035985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Moderne Medikamentenentwicklung durch den Einbezug künstlicher Intelligenz 通过人工智能实现现代药物开发
InFo Hämatologie + Onkologie Pub Date : 2024-05-01 DOI: 10.1007/s15004-024-0597-y
Tobias Seibt, Filipe Menezes, Razelle Kurzrock, Grzegorz M. Popowicz, Adam Wahida
{"title":"Moderne Medikamentenentwicklung durch den Einbezug künstlicher Intelligenz","authors":"Tobias Seibt, Filipe Menezes, Razelle Kurzrock, Grzegorz M. Popowicz, Adam Wahida","doi":"10.1007/s15004-024-0597-y","DOIUrl":"https://doi.org/10.1007/s15004-024-0597-y","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"1984 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141027731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Large Language Models zur Auswertung von Patientendaten in der Onkologie 用于分析肿瘤学患者数据的大型语言模型
InFo Hämatologie + Onkologie Pub Date : 2024-05-01 DOI: 10.1007/s15004-024-0565-6
Anne Moslmani, C. Thielscher
{"title":"Large Language Models zur Auswertung von Patientendaten in der Onkologie","authors":"Anne Moslmani, C. Thielscher","doi":"10.1007/s15004-024-0565-6","DOIUrl":"https://doi.org/10.1007/s15004-024-0565-6","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"33 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141044965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Besseres Gesamtüberleben beim r/r DLBCL r/r DLBCL的总生存率更高
InFo Hämatologie + Onkologie Pub Date : 2024-05-01 DOI: 10.1007/s15004-024-0586-1
Redaktion Facharztmagazine
{"title":"Besseres Gesamtüberleben beim r/r DLBCL","authors":"Redaktion Facharztmagazine","doi":"10.1007/s15004-024-0586-1","DOIUrl":"https://doi.org/10.1007/s15004-024-0586-1","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"48 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141049211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oberärztin in der Maximalversorgung 最高护理级别的高级医师
InFo Hämatologie + Onkologie Pub Date : 2024-05-01 DOI: 10.1007/s15004-024-0491-7
Sabrina Sulzer, Tabea Constanze Fröhlich
{"title":"Oberärztin in der Maximalversorgung","authors":"Sabrina Sulzer, Tabea Constanze Fröhlich","doi":"10.1007/s15004-024-0491-7","DOIUrl":"https://doi.org/10.1007/s15004-024-0491-7","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"106 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141056861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信